Celltrion
068270.KS
#716
Rank
A$42.93 B
Marketcap
$197.21
Share price
0.23%
Change (1 day)
-2.72%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.95. In 2022 the company made an earnings per share (EPS) of $4.81 a decrease over its 2021 EPS that were of $5.72.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.50-6.6%
2022$4.81-15.84%
2021$5.7212.77%
2020$5.0770.79%
2019$2.9715.63%
2018$2.57-33.13%
2017$3.84141.17%
2016$1.598.28%
2015$1.4711.28%
2014$1.3216.37%
2013$1.14-67.42%
2012$3.4984.22%
2011$1.8962.13%
2010$1.1780.61%
2009$0.65-559.63%
2008-$0.14-123.16%
2007$0.61